Fmr LLC grew its holdings in shares of Enovis Co. (NYSE:ENOV – Free Report) by 20.5% during the third quarter, according to ...

Check the time stamp on this data. Updated AI-Generated Signals for Enovis Corporation (ENOV) available here: ENOV.

Caitlin Cronin, an analyst from Canaccord Genuity, maintained the Buy rating on Enovis (ENOV – Research Report). The associated price target ...

Shares of Enovis Co. (NYSE:ENOV – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine research ...

Shares of Enovis (ENOV) have gained 23.6% over the past four weeks to close the last trading session at $47.86, but there could still be a solid upside left in the stock if short-term price ...

Conference call/Webcast Information Investors WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to ...

Enovis (ENOV) came out with quarterly earnings of $0.73 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.56 per share a year ago. These figures ...

In trading on Monday, shares of Enovis Corp (Symbol: ENOV) crossed above their 200 day moving average of $49.01, changing hands as high as $49.32 per share. Enovis Corp shares are currently ...

Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says JMP Securities initiates coverage on Enovis Corporation with a Market Outperform rating ...